Published in this latest issue of the New England Journal of Medicine, this article recounts the lessons we’ve learned in addressing the HIV pandemic in Africa and how those lessons could and should be used to inform COVID-19 vaccine access in Africa. Infrastructure, stigma, acceptability of treatment/vaccines, and delays in safety of drugs among pregnant women and children have long stagnated progress in HIV elimination, and these factors will also affect COVID-19 prevention in low-income countries.
